Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Impact of Cell Composition and Geometry on Human Induced Pluripotent Stem Cells-Derived Engineered Cardiac Tissue.

Nakane T, Masumoto H, Tinney JP, Yuan F, Kowalski WJ, Ye F, LeBlanc AJ, Sakata R, Yamashita JK, Keller BB.

Sci Rep. 2017 Apr 3;7:45641. doi: 10.1038/srep45641.

2.

The myocardial regenerative potential of three-dimensional engineered cardiac tissues composed of multiple human iPS cell-derived cardiovascular cell lineages.

Masumoto H, Nakane T, Tinney JP, Yuan F, Ye F, Kowalski WJ, Minakata K, Sakata R, Yamashita JK, Keller BB.

Sci Rep. 2016 Jul 20;6:29933. doi: 10.1038/srep29933.

3.

Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.

Wendel JS, Ye L, Tao R, Zhang J, Zhang J, Kamp TJ, Tranquillo RT.

Stem Cells Transl Med. 2015 Nov;4(11):1324-32. doi: 10.5966/sctm.2015-0044. Epub 2015 Sep 14.

4.

Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue.

Iseoka H, Miyagawa S, Fukushima S, Saito A, Masuda S, Yajima S, Ito E, Sougawa N, Takeda M, Harada A, Lee JK, Sawa Y.

Tissue Eng Part A. 2018 Feb;24(3-4):287-300. doi: 10.1089/ten.TEA.2016.0535. Epub 2017 Jun 13.

5.

Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration.

Masumoto H, Ikuno T, Takeda M, Fukushima H, Marui A, Katayama S, Shimizu T, Ikeda T, Okano T, Sakata R, Yamashita JK.

Sci Rep. 2014 Oct 22;4:6716. doi: 10.1038/srep06716.

6.

Engineered Cardiac Tissues Generated from Immature Cardiac and Stem Cell-Derived Cells: Multiple Approaches and Outcomes.

Keller BB, Ye F, Yuan F, Trada H, Tinney JP, Walsh KM, Masumoto H.

In: Nakanishi T, Markwald RR, Baldwin HS, Keller BB, Srivastava D, Yamagishi H, editors. Etiology and Morphogenesis of Congenital Heart Disease: From Gene Function and Cellular Interaction to Morphology [Internet]. Tokyo: Springer; 2016. Chapter 46.
2016 Jun 25.

7.

Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.

Altomare C, Pianezzi E, Cervio E, Bolis S, Biemmi V, Benzoni P, Camici GG, Moccetti T, Barile L, Vassalli G.

Europace. 2016 Dec;18(suppl 4):iv67-iv76. doi: 10.1093/europace/euw352.

PMID:
28011833
8.

Myocyte-depleted engineered cardiac tissues support therapeutic potential of mesenchymal stem cells.

Serrao GW, Turnbull IC, Ancukiewicz D, Kim DE, Kao E, Cashman TJ, Hadri L, Hajjar RJ, Costa KD.

Tissue Eng Part A. 2012 Jul;18(13-14):1322-33. doi: 10.1089/ten.TEA.2011.0278. Epub 2012 Jun 25.

9.

Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells.

Weinberger F, Breckwoldt K, Pecha S, Kelly A, Geertz B, Starbatty J, Yorgan T, Cheng KH, Lessmann K, Stolen T, Scherrer-Crosbie M, Smith G, Reichenspurner H, Hansen A, Eschenhagen T.

Sci Transl Med. 2016 Nov 2;8(363):363ra148.

PMID:
27807283
10.

Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell-Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine.

Gao L, Gregorich ZR, Zhu W, Mattapally S, Oduk Y, Lou X, Kannappan R, Borovjagin AV, Walcott GP, Pollard AE, Fast VG, Hu X, Lloyd SG, Ge Y, Zhang J.

Circulation. 2018 Apr 17;137(16):1712-1730. doi: 10.1161/CIRCULATIONAHA.117.030785. Epub 2017 Dec 12.

PMID:
29233823
12.

Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.

Citro L, Naidu S, Hassan F, Kuppusamy ML, Kuppusamy P, Angelos MG, Khan M.

PLoS One. 2014 Dec 31;9(12):e116281. doi: 10.1371/journal.pone.0116281. eCollection 2014.

13.

CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.

Zhu W, Zhao M, Mattapally S, Chen S, Zhang J.

Circ Res. 2018 Jan 5;122(1):88-96. doi: 10.1161/CIRCRESAHA.117.311504. Epub 2017 Oct 10.

PMID:
29018036
14.

In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts.

Kadota S, Pabon L, Reinecke H, Murry CE.

Stem Cell Reports. 2017 Feb 14;8(2):278-289. doi: 10.1016/j.stemcr.2016.10.009. Epub 2017 Jan 5.

15.

Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.

Khan M, Xu Y, Hua S, Johnson J, Belevych A, Janssen PM, Gyorke S, Guan J, Angelos MG.

PLoS One. 2015 May 19;10(5):e0126338. doi: 10.1371/journal.pone.0126338. eCollection 2015. Erratum in: PLoS One. 2015;10(10):e0141176.

16.

Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.

Zwi-Dantsis L, Huber I, Habib M, Winterstern A, Gepstein A, Arbel G, Gepstein L.

Eur Heart J. 2013 Jun;34(21):1575-86. doi: 10.1093/eurheartj/ehs096. Epub 2012 May 22.

PMID:
22621821
17.

Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.

Streckfuss-Bömeke K, Wolf F, Azizian A, Stauske M, Tiburcy M, Wagner S, Hübscher D, Dressel R, Chen S, Jende J, Wulf G, Lorenz V, Schön MP, Maier LS, Zimmermann WH, Hasenfuss G, Guan K.

Eur Heart J. 2013 Sep;34(33):2618-29. doi: 10.1093/eurheartj/ehs203. Epub 2012 Jul 12.

PMID:
22798560
18.

Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells.

Ye L, Chang YH, Xiong Q, Zhang P, Zhang L, Somasundaram P, Lepley M, Swingen C, Su L, Wendel JS, Guo J, Jang A, Rosenbush D, Greder L, Dutton JR, Zhang J, Kamp TJ, Kaufman DS, Ge Y, Zhang J.

Cell Stem Cell. 2014 Dec 4;15(6):750-61. doi: 10.1016/j.stem.2014.11.009. Erratum in: Cell Stem Cell. 2015 Jan 8;16(1):102.

19.

Human stem cell-based three-dimensional microtissues for advanced cardiac cell therapies.

Emmert MY, Wolint P, Wickboldt N, Gemayel G, Weber B, Brokopp CE, Boni A, Falk V, Bosman A, Jaconi ME, Hoerstrup SP.

Biomaterials. 2013 Sep;34(27):6339-54. doi: 10.1016/j.biomaterials.2013.04.034. Epub 2013 May 30.

PMID:
23727259
20.

Neonatal mouse-derived engineered cardiac tissue: a novel model system for studying genetic heart disease.

de Lange WJ, Hegge LF, Grimes AC, Tong CW, Brost TM, Moss RL, Ralphe JC.

Circ Res. 2011 Jun 24;109(1):8-19. doi: 10.1161/CIRCRESAHA.111.242354. Epub 2011 May 12. Erratum in: Circ Res. 2012 May 25;110(11):e91.

Supplemental Content

Support Center